Abstract: A buffing and polishing pad or other structure uses extremely fine microfibers of less than 1 denier. Preferred fibers are less than 0.7 denier, and in some cases considerably less. The currently most preferred embodiment is 50% fiber having 0.5 denier and 50% fiber having 0.3 denier. Preferred fibers have an average fiber length of between about 70 and about 90 mm, and most preferably about 80 mm. The fibers can be any suitable material, natural or synthetic, including especially polyester. A layer of the fibers is preferably made on a circular knitting machine.

Abstract: The invention relates to elastomeric compositions for use as temporary or semi-permanent protective coatings. The coatings are particularly useful to protect objects in transit. In certain embodiments, the compositions are based on monomer units of isoprene or isoprene derivatives. Preferably, the compositions include a reinforcement agent encapsulated in the polymer to reinforce the polymer structure, making it more resistant to environmental conditions, including heat and chemicals. Example reinforcement agents include particles of clays, ceramics, and/or nano-particles.

Abstract: A buffing and polishing pad or other structure uses extremely fine microfibers of less than 1 denier. Preferred fibers are less than 0.7 denier, and in some cases considerably less. The currently most preferred embodiment is 50% fiber having 0.5 denier and 50% fiber having 0.3 denier. Preferred fibers have an average fiber length of between about 70 and about 90 mm, and most preferably about 80 mm. The fibers can be any suitable material, natural or synthetic, including especially polyester. The fibers are preferably made on a circular knitting machine.

Abstract: The present invention is directed to novel pyrazole derivatives and their use as pesticidal agents.

Abstract: The present invention is directed to novel pyrazole derivatives and their use as pesticidal agents. The pyrazole derivatives have Formula I: or a salt thereof, where R1 represents R5O, R5SO2, R5SO or R5S in which R5 is as defined herein; X is halo, cyano, C1-6 alkoxycarbonyl, C2-6 alkynyl, optionally substituted C6-14 aryl or an optionally substituted 5- to 7-membered heteroaromatic ring linked to thiazole via a carbon-carbon bond; R2 is hydrogen, amino, chloro, bromo, iodo, cyano, C1-6 alkoxy, C1-6 alkyl or C6-10 aryl; and R3-R7 each represent hydrogen, halogen, straight- or branched-chain C1-4 alkyl or C1-4 alkoxy, either of which is unsubstituted or substituted by one or more halogen atoms, straight- or branched-chain C1-4 alkylthio or C1-4 alkylsulphinyl, either of which is substituted by one or more halogen atoms, nitro, cyano, or straight- or branched-chain C1-4 alkylsulphonyl group which is unsubstituted or substituted by one or more halogen atoms.

Abstract: The present invention relates to flea serine protease proteins, aminopeptidase proteins and flea cysteine protease proteins; to flea serine protease, aminopeptidase and cysteine protease nucleic acid molecules, including those that encode such proteins; to antibodies raised against such proteins; and to compounds that inhibit flea serine protease, aminopeptidase and/or cysteine protease activities. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitors. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies, and/or inhibitors as well as the use of such therapeutic compositions to protect a host animal from flea infestation.

Abstract: The present invention relates to flea serine protease proteins, aminopeptidase proteins and flea cysteine protease proteins; to flea serine protease, aminopeptidase and cysteine protease nucleic acid molecules, including those that encode such proteins; to antibodies raised against such proteins; and to compounds that inhibit flea serine protease, aminopeptidase and/or cysteine protease activities. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitors. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies, and/or inhibitors as well as the use of such therapeutic compositions to protect a host animal from flea infestation.

Abstract: Unitary casting devices are provided for making casts and splints. In one embodiment, the device includes a padding layer for contact with the patient, a non-hydrophilic, water-permeable inner protective layer juxtaposed against the padding layer, a casting layer comprising a liquid-activatable casting material placed along the inner protective layer, a liquid-impermeable, water vapor permeable first outer protective layer juxtaposed against the casting layer and a non-hydrophilic, water-permeable second outer protective layer juxtaposed against the first outer protective layer. The device also includes means for holding the layers together to form a unitary device. In other embodiments of the unitary device, the device further includes inner and outer water containment layers including a liquid-impermeable, water vapor permeable material such that the device need not be immersible, but may contain its own supply of activating liquid or have liquid introduced into the device.